ANI PHARMACEUTICALS, INC Accrued Royalties, Current
ANI PHARMACEUTICALS, INC (ANIP) had Accrued Royalties, Current of $55.83 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:AccruedRoyaltiesCurrent · last filed 2026-08-07
- 2026-06-30: Accrued Royalties, Current $55.83M.
- 2026-03-31: Accrued Royalties, Current $33.93M.
- 2025-12-31: Accrued Royalties, Current $48.50M.
- 2025-09-30: Accrued Royalties, Current $51.25M.
| Period end | Accrued Royalties, Current |
|---|---|
| 2026-06-30 | $55.83M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $33.93M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $48.50M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $51.25M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $36.03M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $23.71M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $22.63M 10-K · filed 2026-02-27 |
| 2024-09-30 | $23.45M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $20.36M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $15.47M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $16.28M 10-K · filed 2025-02-28 |
| 2023-09-30 | $11.97M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $9.88M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $8.96M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $9.31M 10-K · filed 2024-02-29 |
| 2022-09-30 | $6.58M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $6.29M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $5.00M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $6.22M 10-K · filed 2023-03-09 |
| 2021-09-30 | $4.00M 10-Q · filed 2021-11-01 |
| 2021-06-30 | $4.69M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $5.31M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $6.41M 10-K · filed 2022-03-15 |
| 2020-09-30 | $6.09M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $6.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $6.29M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.08M 10-K · filed 2021-03-11 |
| 2019-09-30 | $5.53M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $6.26M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $5.44M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $8.46M 10-K · filed 2020-02-27 |
| 2018-09-30 | $7.46M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $8.22M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $11.36M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $12.16M 10-K · filed 2019-02-27 |
| 2017-09-30 | $11.74M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $11.26M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $10.33M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $11.96M 10-K · filed 2018-02-27 |
| 2016-09-30 | $11.77M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $8.11M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $4.63M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $606.00K 10-K · filed 2017-03-02 |
| 2014-12-31 | $702.00K 10-K · filed 2016-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |